CD274 and neoplasm: Recent researches have shown that programmed death ligand 1 (PD-L1) expression in tumor cells and the density of tumor-associated immune cells (TAICs) can serve as biomarkers for survival outcomes in oral squamous cell carcinoma (OSCC) [1-5].